Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is there an association between acute, subacute, and late genitourinary quality of life with prostate SBRT boost?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Stromal Cell Subsets Modulate T-cell Infiltration in Early Breast Cancer.

Cancer research communications·2026
Same author

Plasma proteomics implicates NOX-driven redox imbalance in degenerative cervical myelopathy: findings from the Australian MYelopathy Natural History Registry [AO Spine RECODE-DCM research priority number 5].

Redox report : communications in free radical research·2026
Same author

Toxicities and Quality of Life following Observation or Radiation Therapy for Dupuytren's Disease: Three-Year Secondary Analysis Data From the Prevention Group of the International Dupuytren's Evaluation of Preventative or Adjuvant Radiation Therapy (DEPART) Randomized Trial.

International journal of radiation oncology, biology, physics·2025
Same author

Dosimetric Clues to Addressing Urinary Toxicity Following Stereotactic Prostate Radiation Therapy.

Advances in radiation oncology·2025
Same author

Enzymes Drive Glutathione Shunt to Explain Oxidative State Using an In-Parallel Multi-Omic Method.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jun 19, 2025

Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
09:28

Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery

Published on: October 27, 2023

2.9K

Optimising Extracellular Vesicle Metabolomic Methodology for Prostate Cancer Biomarker Discovery.

Mahmoud Assem Hamed1,2, Valerie Wasinger3, Qi Wang1,2

  • 1St. George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales (UNSW) Sydney, Kensington, NSW 2052, Australia.

Metabolites
|July 26, 2024
PubMed
Summary

This study optimized extracellular vesicle (EV) metabolomics for prostate cancer (PCa) detection. A novel methanol-microbeads approach effectively identified key PCa biomarkers in EVs, improving early diagnosis potential.

Keywords:
biomarker discoverychromatography columnsextracellular vesiclesmetabolite extractionmetabolomicsprostate cancer

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.8K
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

358

Related Experiment Videos

Last Updated: Jun 19, 2025

Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
09:28

Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery

Published on: October 27, 2023

2.9K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.8K
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

358

Area of Science:

  • Biochemistry
  • Oncology
  • Biomarker Discovery

Background:

  • Conventional prostate cancer (PCa) diagnostics like PSA tests have limitations in accuracy and invasiveness.
  • Liquid biopsy and extracellular vesicle (EV) metabolomics offer promising, less invasive alternatives for PCa detection.
  • Accurate biomarkers for early PCa diagnosis and monitoring are critically needed.

Purpose of the Study:

  • To evaluate and optimize metabolite extraction and separation methods for extracellular vesicle (EV) metabolomics in PCa.
  • To identify potential PCa biomarkers through comprehensive analysis of EV metabolic cargo.
  • To establish a robust protocol for EV metabolomics in PCa biomarker discovery.

Main Methods:

  • Evaluated four distinct metabolite extraction approaches for large EVs (lEVs) derived from PC3 cells.
  • Utilized methanol, microbead cell shearing, size exclusion filtration, and pHILIC/C18 chromatography.
  • Employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) for metabolite analysis.

Main Results:

  • The unfiltered methanol-microbeads (MB-UF) approach combined with pHILIC LC-MS/MS proved effective for EV metabolite extraction.
  • Identified key metabolites including L-glutamic acid, pyruvic acid, lactic acid, and methylmalonic acid with links to PCa.
  • Demonstrated the importance of optimizing extraction and separation for downstream omics integrity.

Conclusions:

  • The optimized MB-UF and pHILIC LC-MS/MS protocol is effective for PCa EV metabolomics.
  • Identified metabolites show potential as biomarkers for early PCa diagnosis and monitoring.
  • This study provides a foundation for advanced EV metabolomics in PCa research and clinical application.